52
Participants
Start Date
June 12, 2019
Primary Completion Date
March 30, 2021
Study Completion Date
March 31, 2021
Linezolid
For both experimental arms: 1.2g linezolid 28 days, followed by 600mg linezolid for 28 days
High dose rifampicin
For both experimental arms: additional 25mg/kg (making a total of 35mg/kg) rifampicin, for the first 56 days of treatment
Aspirin
For only one of the experimental arms: 1000mg of aspirin daily for 56 days.
Standard of Care anti-tuberculous therapy
10mg/kg oral rifampicin, 5mg/kg oral isoniazid, 15mg/kg oral ethambutol, 25mg/kg oral pyrazinamide daily for 56 days.
Dexamethasone
Dexamethasone according to doses of Thwaites criteria for the first 8 weeks of anti-tuberculous treatment. Doses differ according to participants Medical Research Council (MRC) grade. Given orally if participant can swallow and intravenously if they cannot.
Livingstone Hospital, Port Elizabeth
Mitchells Plain Hospital, Cape Town
Groote Schuur Hospital, Cape Town
New Somerset Hospital, Cape Town
University of Cape Town
OTHER